Corbus Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery

Press Release Webcast

IR Contacts

Investor Relations

Institutional Investor Inquiries:
Corbus Pharmaceuticals, Inc.
Ted Jenkins, Senior Director, Investor Relations and Communications
Phone: 617.415.7745

All Other Investor Inquiries:
Jenene Thomas Communications
Jenene Thomas
Phone: 833.475.8247

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004
Phone: 800.509.5586


EisnerAmper LLP
111 Wood Avenue South
Iselin, NJ 08830-2700
Phone: 732.243.7000

Legal Counsel

Lowenstein Sandler LLP
1251 Avenue of the Americas
New York, NY 10020
Phone: 212.262.6700